New Content  edit
Get The App!

Loading the player...
Prostanoids in Pediatric PAH
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
While IV epoprostenol remains the gold standard for the treatment of advanced pediatric PAH, newer agents may be initiated in carefully selected patients. Dr. Erika Berman Rosenzweig of Columbia University, reviews the use of prostanoids in pediatric PAH patients. Recorded at the UCSF 9th Annual Neonatal and Childhood Pulmonary Vascular Disease Conference.